Correlation Between Teva Pharmaceutical and Eisai

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharmaceutical and Eisai at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharmaceutical and Eisai into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharmaceutical Industries and Eisai Co, you can compare the effects of market volatilities on Teva Pharmaceutical and Eisai and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharmaceutical with a short position of Eisai. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharmaceutical and Eisai.

Diversification Opportunities for Teva Pharmaceutical and Eisai

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Teva and Eisai is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and Eisai Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eisai and Teva Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharmaceutical Industries are associated (or correlated) with Eisai. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eisai has no effect on the direction of Teva Pharmaceutical i.e., Teva Pharmaceutical and Eisai go up and down completely randomly.

Pair Corralation between Teva Pharmaceutical and Eisai

Assuming the 90 days horizon Teva Pharmaceutical Industries is expected to generate 2.08 times more return on investment than Eisai. However, Teva Pharmaceutical is 2.08 times more volatile than Eisai Co. It trades about 0.24 of its potential returns per unit of risk. Eisai Co is currently generating about -0.1 per unit of risk. If you would invest  1,620  in Teva Pharmaceutical Industries on September 22, 2024 and sell it today you would earn a total of  500.00  from holding Teva Pharmaceutical Industries or generate 30.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Teva Pharmaceutical Industries  vs.  Eisai Co

 Performance 
       Timeline  
Teva Pharmaceutical 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Teva Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.
Eisai 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eisai Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Teva Pharmaceutical and Eisai Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharmaceutical and Eisai

The main advantage of trading using opposite Teva Pharmaceutical and Eisai positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharmaceutical position performs unexpectedly, Eisai can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eisai will offset losses from the drop in Eisai's long position.
The idea behind Teva Pharmaceutical Industries and Eisai Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation